
Loading, please wait...

Loading, please wait...

India is currently at a critical inflection point in its medical journey. Dr. Naresh Trehan recently emphasized that preventive healthcare in India must become the primary focus. Consequently, this shift aims to solve the healthcare challenges of 1.5 billion people. Historically, global systems have relied on reactive treatments. However, Trehan argues that proactive prevention is the actual solution for the future.
The global wellness market reached a value of USD 1.8 trillion in 2024. Meanwhile, India's preventive market could reach USD 500 billion by 2030. This growth reflects a significant opportunity for medical innovation and talent. Furthermore, the demographic dividend provides a unique platform for large-scale adult vaccination programs. Rajesh Jain of Panacea Biotech envisions India becoming the preventive capital of the world. Consequently, the production of innovative and scalable vaccines will drive this transformation.
V K Paul from NITI Aayog highlighted the importance of universal health coverage. Currently, out-of-pocket expenses are decreasing as insurance coverage expands. However, the private sector must cover many more individuals to ensure success. India needs a reliable and trustworthy insurance system that remains affordable for the masses. This evolution will empower consumers and improve overall health excellence across the nation.
Q1: Why is a shift to preventive healthcare necessary for India?
Dr. Naresh Trehan argues that a reactive treatment model cannot sustainably manage the health needs of 1.5 billion people. Proactive prevention leverages India's scale and talent to improve health outcomes efficiently.
Q2: What is the projected market value of India's preventive healthcare sector?
India's preventive healthcare market is projected to reach USD 500 billion by the year 2030, driven by consumer empowerment and technological innovation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Dr. Naresh Trehan emphasizes shifting India's healthcare from reactive treatment to proactive prevention to serve its 1.5 billion people efficiently by 2030...
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today